John C. Beach

Butyrate, PKM2, and the MYB–HDAC2–FOXA2 Differentiation Axis: Placing the Cho Cancer-Reversion Result in the Context of Prior Short-Chain Fatty Acid Chemistry

Hypothesis commentary linking the Cho et al. cancer-reversion result ""Control of Cellular Differentiation Trajectories for Cancer Reversion" (MYB, HDAC2, FOXA2) toprior butyrate, HDAC, c-Myb, PKM2, and FOXA2 literature, with inferences from the author’s 2022–2024 posts labeled a...